Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
10x Genomics (TXG) had Cash Flow from Financial Activities of $4.56M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$149.00M |
|
$-27.47M |
|
$48.70M |
|
$100.31M |
|
$181.24M |
|
$-32.24M |
|
$4.04M |
|
$-28.20M |
|
$-28.20M |
|
$-27.47M |
|
$-27.47M |
|
$-27.47M |
|
$-27.47M |
|
$-32.24M |
|
$-19.18M |
|
125.50M |
|
125.50M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$659.83M |
|
$232.53M |
|
$367.53M |
|
$1.03B |
|
$147.32M |
|
-- |
|
$94.92M |
|
$242.24M |
|
$785.12M |
|
$715.85M |
|
$785.12M |
|
126.54M |
|
| Cash Flow Statement Financials | |
$95.27M |
|
$-11.63M |
|
|
Cash Flow from Financial Activities |
$4.56M |
$344.07M |
|
$432.71M |
|
$88.64M |
|
$83.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
67.32% |
|
-21.64% |
|
-21.64% |
|
-- |
|
-18.93% |
|
-18.44% |
|
$91.11M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.79 |
|
1.54 |
|
58.34 |
|
-3.50% |
|
-3.84% |
|
-2.67% |
|
-3.50% |
|
$6.20 |
|
$0.73 |
|
$0.76 |
|